secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0000721371-26-000003
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health raises FY2026 non-GAAP EPS outlook to at least $10.00, up from $9.65-$9.85
--------------------------------------------------------------------------------

- Raises FY2026 non-GAAP diluted EPS guidance to at least $10.00 from prior range of $9.65-$9.85.
- Specialty revenues expected to exceed $50B in FY2026, a 16% CAGR over three years.
- Successfully transitioned distribution agreements for all drugs affected by 2026 Medicare Drug Price Negotiation Program.
- Launched ContinuCare Pathway program; Publix enrolled ~1,400 pharmacies, expanding to over 11,000 retail and grocery pharmacies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000003/0000721371-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000003/cah-20260113.htm
  HTML page:      https://secwatch.observer/filing/0000721371-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer